Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Tables)

v3.21.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
    As of December 31,  
    2020     2019  
In respect of:            
Net operating loss carry forward   $ 13,170     $ 12,607  
Research and development expenses     820       801  
Valuation of financial instruments     (10 )     -  
Less – valuation allowance     (13,980 )     (13,408 )
Net deferred tax assets   $ -     $ -  
Summary of Valuation Allowance [Table Text Block]
Balance at January 1, 2018   $ 11,155  
Additions     (232 )
Balance at December 31, 2018   $ 10,923  
Additions     2,485  
Balance at December 31, 2019   $ 13,408  
Additions     572  
Balance at December 31, 2020   $ 13,980